Demet Gür Vural
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Demet Gür Vural has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Kemal Bilgin
Ondokuz Mayıs Üniversitesi Tıp Fakültesi, Tıbbi Mikrobiyoloji Anabilim Dalı, Samsun
24 shared publications - Yeliz Tanrıverdi Çaycı
Ondokuz Mayıs Üniversitesi, Tıp Fakültesi, Tıbbi Mikrobiyoloji Anabilim Dalı, Samsun, Türkiye
23 shared publications - Asuman Birinci
Ondokuz Mayıs Üniversitesi, Tıp Fakültesi, Tıbbi Mikrobiyoloji Anabilim Dalı, Samsun, Türkiye
18 shared publications - Canberk Çınar
Ondokuz Mayıs Üniversitesi Tıp Fakültesi, Tıbbi Mikrobiyoloji Anabilim Dalı, Samsun
10 shared publications - Asuman Birinci
Department of Medical Microbiology, Faculty of Medicine, Ondokuz Mayıs University, 55139 Samsun, Turkey
4 shared publications - Elif Ateş
Ondokuz Mayıs Üniversitesi Tıp Fakültesi, Tıbbi Mikrobiyoloji Anabilim Dalı, Samsun
3 shared publications
Latest Publications
- 28 October 2026
- Published by Bilimsel Tip Publishing House in Mikrobiyoloji Bulteni
- Vol. 60 (4) , 494-506
Yoğun Bakım Hastalarının İdrar Örneklerinden İzole Edilen Candida Türlerinde Biyofilm Oluşumunun ve als1, hwp1 ve sap1 Genlerinin PCR ile Araştırılması
- 28 October 2026
- Published by Bilimsel Tip Publishing House in Mikrobiyoloji Bulteni
- Vol. 60 (4) , 494-506
Yoğun Bakım Hastalarının İdrar Örneklerinden İzole Edilen Candida Türlerinde Biyofilm Oluşumunun ve als1, hwp1 ve sap1 Genlerinin PCR ile Araştırılması
- Open Access
- 11 October 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (20) , 3302
Performance of Direct Identification and EUCAST Rapid Antimicrobial Susceptibility Testing in Bloodstream Infections Using Sepsityper® and Disk Diffusion Methods
Background/Objectives: Rapid pathogen identification and targeted antimicrobial susceptibility testing (AST) in bloodstream infections are critical to reducing sepsis-related mortality. This study aimed to evaluate the performance of direct MALDI-TOF MS identification using the rapid Sepsityper® kit and to determine the diagnostic accuracy and reliability of the EUCAST Rapid Antimicrobial Susceptibility Testing (RAST) protocol at various incubation periods (4, 6, 8, and 16–20 h) from positive blood culture bottles. Methods: A total of 71 clinical isolates recovered from positive blood cultures in the Medical Microbiology Laboratory of Ondokuz Mayıs University Faculty of Medicine were included. Samples prepared directly using the rapid Sepsityper® kit were identified via MALDI-TOF MS, while the EUCAST RAST protocol was simultaneously performed on Mueller–Hinton agar using disk panels guided by Gram stain results. Results were analyzed for Categorical Agreement (CA), major errors, and very major errors using routine automated AST data as the reference standard. Results: The rapid Sepsityper® kit successfully identified 51 of 71 isolates (71.8%) at the species level within 30–60 min. The overall categorical agreement of EUCAST RAST with the automated system increased from 67.5% at 4 h to 76.6% at 6 h, 82.7% at 8 h, and 87.0% at 16–20 h. With prolonged incubation, the major error rate dropped significantly from 51.3% to 3.8%. However, the very major error rate remained at 8.1% in final readings, with these errors predominantly clustering in carbapenems and fluoroquinolones among Klebsiella pneumoniae strains. Conclusions: The rapid Sepsityper® kit provides species-level identification in under an hour in approximately three-quarters of cases, facilitating the early de-escalation of empirical therapy. Although EUCAST RAST categorical agreement improves progressively with time, conventional methods are still recommended for confirmation due to the risk of very major errors, particularly in detecting carbapenem resistance.
- 11 October 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (20) , 3302
Open AccessPerformance of Direct Identification and EUCAST Rapid Antimicrobial Susceptibility Testing in Bloodstream Infections Using Sepsityper® and Disk Diffusion Methods
Background/Objectives: Rapid pathogen identification and targeted antimicrobial susceptibility testing (AST) in bloodstream infections are critical to reducing sepsis-related mortality. This study aimed to evaluate the performance of direct MALDI-TOF MS identification using the rapid Sepsityper® kit and to determine the diagnostic accuracy and reliability of the EUCAST Rapid Antimicrobial Susceptibility Testing (RAST) protocol at various incubation periods (4, 6, 8, and 16–20 h) from positive blood culture bottles. Methods: A total of 71 clinical isolates recovered from positive blood cultures in the Medical Microbiology Laboratory of Ondokuz Mayıs University Faculty of Medicine were included. Samples prepared directly using the rapid Sepsityper® kit were identified via MALDI-TOF MS, while the EUCAST RAST protocol was simultaneously performed on Mueller–Hinton agar using disk panels guided by Gram stain results. Results were analyzed for Categorical Agreement (CA), major errors, and very major errors using routine automated AST data as the reference standard. Results: The rapid Sepsityper® kit successfully identified 51 of 71 isolates (71.8%) at the species level within 30–60 min. The overall categorical agreement of EUCAST RAST with the automated system increased from 67.5% at 4 h to 76.6% at 6 h, 82.7% at 8 h, and 87.0% at 16–20 h. With prolonged incubation, the major error rate dropped significantly from 51.3% to 3.8%. However, the very major error rate remained at 8.1% in final readings, with these errors predominantly clustering in carbapenems and fluoroquinolones among Klebsiella pneumoniae strains. Conclusions: The rapid Sepsityper® kit provides species-level identification in under an hour in approximately three-quarters of cases, facilitating the early de-escalation of empirical therapy. Although EUCAST RAST categorical agreement improves progressively with time, conventional methods are still recommended for confirmation due to the risk of very major errors, particularly in detecting carbapenem resistance.
- Open Access
- 1 October 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2224
Investigation of Carbapenemase Resistance Genes and Plasmid-Mediated Quinolone Resistance Genes in Ceftolozane/Tazobactam-Resistant Enterobacterales and Pseudomonas aeruginosa Isolates
Objectives: Carbapenem-resistant Gram-negative bacteria limit treatment options for hospital-acquired infections, and resistance to ceftolozane/tazobactam is increasingly reported. This study investigated the distribution of carbapenemase and plasmid-mediated quinolone resistance (PMQR) genes among ceftolozane/tazobactam-resistant Enterobacterales and Pseudomonas aeruginosa isolates. Methods: We analyzed 224 non-duplicate ceftolozane/tazobactam-resistant clinical isolates (145 Enterobacterales and 79 P. aeruginosa) collected at Ondokuz Mayıs University Faculty of Medicine Hospital between January 2024 and March 2025. Species were identified by MALDI-TOF MS, and minimum inhibitory concentrations were determined with the BD Phoenix system and interpreted according to EUCAST breakpoints (v15.0; resistant: >2 mg/L for Enterobacterales, >4 mg/L for P. aeruginosa). Carbapenemase (blaOXA-48, blaNDM, blaKPC, blaVIM, blaIMP) and PMQR (qnrA, qnrB, qnrC, qnrS) genes were detected by multiplex PCR. Results: Among Enterobacterales (82.8% Klebsiella pneumoniae), blaOXA-48 was the most frequent carbapenemase gene (50.3%), followed by blaNDM (25.5%) and blaKPC (17.2%); 24.8% of isolates carried none of the tested genes. qnrB was the most common PMQR gene (27.6%). Among P. aeruginosa, blaVIM (34.2%) and blaNDM(15.2%) were detected, and 51.9% of isolates were negative for all tested carbapenemase genes. PMQR genes were rare in P. aeruginosa (qnrB, 2.5%). blaIMP and qnrC were not detected in either group. Conclusions: Carbapenemase genes, mainly blaOXA-48 in Enterobacterales and blaVIM in P. aeruginosa, were common among ceftolozane/tazobactam-resistant isolates, but many isolates were negative for all tested genes, suggesting that other mechanisms are involved. Because only resistant isolates were studied, these findings describe gene distribution and do not establish its contribution to resistance. Continued molecular surveillance is needed to support local treatment and infection control decisions.
- 1 October 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2224
Open AccessInvestigation of Carbapenemase Resistance Genes and Plasmid-Mediated Quinolone Resistance Genes in Ceftolozane/Tazobactam-Resistant Enterobacterales and Pseudomonas aeruginosa Isolates
Objectives: Carbapenem-resistant Gram-negative bacteria limit treatment options for hospital-acquired infections, and resistance to ceftolozane/tazobactam is increasingly reported. This study investigated the distribution of carbapenemase and plasmid-mediated quinolone resistance (PMQR) genes among ceftolozane/tazobactam-resistant Enterobacterales and Pseudomonas aeruginosa isolates. Methods: We analyzed 224 non-duplicate ceftolozane/tazobactam-resistant clinical isolates (145 Enterobacterales and 79 P. aeruginosa) collected at Ondokuz Mayıs University Faculty of Medicine Hospital between January 2024 and March 2025. Species were identified by MALDI-TOF MS, and minimum inhibitory concentrations were determined with the BD Phoenix system and interpreted according to EUCAST breakpoints (v15.0; resistant: >2 mg/L for Enterobacterales, >4 mg/L for P. aeruginosa). Carbapenemase (blaOXA-48, blaNDM, blaKPC, blaVIM, blaIMP) and PMQR (qnrA, qnrB, qnrC, qnrS) genes were detected by multiplex PCR. Results: Among Enterobacterales (82.8% Klebsiella pneumoniae), blaOXA-48 was the most frequent carbapenemase gene (50.3%), followed by blaNDM (25.5%) and blaKPC (17.2%); 24.8% of isolates carried none of the tested genes. qnrB was the most common PMQR gene (27.6%). Among P. aeruginosa, blaVIM (34.2%) and blaNDM(15.2%) were detected, and 51.9% of isolates were negative for all tested carbapenemase genes. PMQR genes were rare in P. aeruginosa (qnrB, 2.5%). blaIMP and qnrC were not detected in either group. Conclusions: Carbapenemase genes, mainly blaOXA-48 in Enterobacterales and blaVIM in P. aeruginosa, were common among ceftolozane/tazobactam-resistant isolates, but many isolates were negative for all tested genes, suggesting that other mechanisms are involved. Because only resistant isolates were studied, these findings describe gene distribution and do not establish its contribution to resistance. Continued molecular surveillance is needed to support local treatment and infection control decisions.
- Open Access
- 1 September 2026
- Published by Turkish Society of Microbiology
- Vol. 56 (3) , 263-271
Ondokuz Mayıs Üniversitesi Tıp Fakültesi Hastanesi’nde Karaciğer Yerleşimli Kistik Ekinokokkoz Şüpheli Olguların Serolojik Bulguları ve Radyolojik Kist Evreleri: Beş Yıllık Retrospektif Değerlendirme
Amaç: Kistik ekinokokkoz (KE), Echinococcus granulosus’un larva formunun neden olduğu, en sık karaciğeri tutan önemli bir zoonotik hastalıktır. Bu çalışmada, karaciğer yerleşimli KE şüphesiyle laboratuvarımıza gönderilen hastalardan elde edilen serum örneklerinde ELISA ve indirekt hemaglütinasyon (İHA) yöntemlerinin serolojik sonuçlarının karşılaştırılması, testler arasındaki uyumun değerlendirilmesi ve serolojik bulguların Dünya Sağlık Örgütü İnformal Ekinokokkoz Çalışma Grubu (WHO-IWGE) kist evreleriyle ilişkisinin incelenmesi amaçlanmıştır. Yöntem: Ocak 2020–Aralık 2024 tarihleri arasında laboratuvarımıza gönderilen toplam 641 hastaya ait serum örnekleri retrospektif olarak incelenmiştir. Echinococcus granulosus IgG antikorları ELISA (EUROIMMUN, Almanya) ve IHA (ELITech Group, Fransa) yöntemleriyle araştırılmıştır. Seropozitif ve sınırda (borderline) olarak değerlendirilen olguların radyolojik bulguları WHO-IWGE sınıflamasına göre incelenmiş, testler arasındaki uyum “Cohen’s kappa” katsayısı ile analiz edilmiştir. Bulgular: Çalışmaya alınan 641 hastanın 395’i kadın, 246’sı erkek olup yaş ortalaması 38,2±11,8 yıldır. Seropozitiflik oranı %15 (n=96), borderline sonuç oranı %5 (n=32) olarak saptanmıştır. ELISA ve IHA’nın birlikte çalışıldığı 258 olguda testler arasında güçlü uyum gözlenmiştir (κ=0,82; p<0,001). Radyolojik olarak doğrulanan 99 olgunun 84’ünde aktif evre (CE1–CE3), 15’inde inaktif evre (CE4–CE5) kistler bulunmuş; sınırda bulunan sonuçların tamamı inaktif evre kistlerle ilişkilendirilmiştir. Sonuç: ELISA ve IHA testleri KE tanısında birbirini tamamlayıcı yöntemler olarak değerlendirilebilir. Serolojik sonuçların kist evresi ve radyolojik bulgularla birlikte yorumlanması, tanısal yaklaşımın güvenilirliğini artırmaktadır.
- 1 September 2026
- Published by Turkish Society of Microbiology
- Vol. 56 (3) , 263-271
Open AccessOndokuz Mayıs Üniversitesi Tıp Fakültesi Hastanesi’nde Karaciğer Yerleşimli Kistik Ekinokokkoz Şüpheli Olguların Serolojik Bulguları ve Radyolojik Kist Evreleri: Beş Yıllık Retrospektif Değerlendirme
Amaç: Kistik ekinokokkoz (KE), Echinococcus granulosus’un larva formunun neden olduğu, en sık karaciğeri tutan önemli bir zoonotik hastalıktır. Bu çalışmada, karaciğer yerleşimli KE şüphesiyle laboratuvarımıza gönderilen hastalardan elde edilen serum örneklerinde ELISA ve indirekt hemaglütinasyon (İHA) yöntemlerinin serolojik sonuçlarının karşılaştırılması, testler arasındaki uyumun değerlendirilmesi ve serolojik bulguların Dünya Sağlık Örgütü İnformal Ekinokokkoz Çalışma Grubu (WHO-IWGE) kist evreleriyle ilişkisinin incelenmesi amaçlanmıştır. Yöntem: Ocak 2020–Aralık 2024 tarihleri arasında laboratuvarımıza gönderilen toplam 641 hastaya ait serum örnekleri retrospektif olarak incelenmiştir. Echinococcus granulosus IgG antikorları ELISA (EUROIMMUN, Almanya) ve IHA (ELITech Group, Fransa) yöntemleriyle araştırılmıştır. Seropozitif ve sınırda (borderline) olarak değerlendirilen olguların radyolojik bulguları WHO-IWGE sınıflamasına göre incelenmiş, testler arasındaki uyum “Cohen’s kappa” katsayısı ile analiz edilmiştir. Bulgular: Çalışmaya alınan 641 hastanın 395’i kadın, 246’sı erkek olup yaş ortalaması 38,2±11,8 yıldır. Seropozitiflik oranı %15 (n=96), borderline sonuç oranı %5 (n=32) olarak saptanmıştır. ELISA ve IHA’nın birlikte çalışıldığı 258 olguda testler arasında güçlü uyum gözlenmiştir (κ=0,82; p<0,001). Radyolojik olarak doğrulanan 99 olgunun 84’ünde aktif evre (CE1–CE3), 15’inde inaktif evre (CE4–CE5) kistler bulunmuş; sınırda bulunan sonuçların tamamı inaktif evre kistlerle ilişkilendirilmiştir. Sonuç: ELISA ve IHA testleri KE tanısında birbirini tamamlayıcı yöntemler olarak değerlendirilebilir. Serolojik sonuçların kist evresi ve radyolojik bulgularla birlikte yorumlanması, tanısal yaklaşımın güvenilirliğini artırmaktadır.
- Open Access
- 31 August 2026
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 20 (08) , 1114-1121
Comparative evaluation of a novel saliva collection strip and nasopharyngeal swab for SARS-CoV-2 validated by in-house RT-qPCR
Introduction: The most commonly used sample collection method for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is nasopharyngeal swab; however, sample collection, especially from pediatric patients, is difficult. Therefore, the aim of this study was to design a saliva collection strip and to compare the effectiveness of this strip with the nasopharyngeal swab. Additionally, the performance of different isolation procedures before real time quantitative polymerase chain reaction (RT-qPCR) were investigated and an in-house RT-qPCR assay was developed. Methodology: A total of 200 samples was collected from patients and 92 samples were confirmed as SARS-CoV-2 positive. In the first technique, nucleic acid from the samples were isolated using different isolation methods, and then analyzed by RT-qPCR. In the second technique, the samples were analyzed directly by RT-qPCR without any isolation process. Additionally, in-house RT-qPCR assay was performed and the results were compared with conventional RT-qPCR. Results: The cycle threshold (Ct) values were compared between the techniques, and very similar results were obtained with all of the methods. This reveals that both sample collection methods, both isolation methods, and both RT-qPCR assays had comparable accuracy. Conclusions: In this study, in-house optimization, validation, and integration of the SARS-CoV-2 assay with both isolation-based and extraction (direct lysis) workflows were compared. In addition, its compatibility with the newly designed saliva strip collection system was analyzed. Very similar results were obtained from all of the methods. Therefore, the sample collection strip and in-house assay can be useful tools for detecting SARS-CoV-2.
- 31 August 2026
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 20 (08) , 1114-1121
Open AccessComparative evaluation of a novel saliva collection strip and nasopharyngeal swab for SARS-CoV-2 validated by in-house RT-qPCR
Introduction: The most commonly used sample collection method for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is nasopharyngeal swab; however, sample collection, especially from pediatric patients, is difficult. Therefore, the aim of this study was to design a saliva collection strip and to compare the effectiveness of this strip with the nasopharyngeal swab. Additionally, the performance of different isolation procedures before real time quantitative polymerase chain reaction (RT-qPCR) were investigated and an in-house RT-qPCR assay was developed. Methodology: A total of 200 samples was collected from patients and 92 samples were confirmed as SARS-CoV-2 positive. In the first technique, nucleic acid from the samples were isolated using different isolation methods, and then analyzed by RT-qPCR. In the second technique, the samples were analyzed directly by RT-qPCR without any isolation process. Additionally, in-house RT-qPCR assay was performed and the results were compared with conventional RT-qPCR. Results: The cycle threshold (Ct) values were compared between the techniques, and very similar results were obtained with all of the methods. This reveals that both sample collection methods, both isolation methods, and both RT-qPCR assays had comparable accuracy. Conclusions: In this study, in-house optimization, validation, and integration of the SARS-CoV-2 assay with both isolation-based and extraction (direct lysis) workflows were compared. In addition, its compatibility with the newly designed saliva strip collection system was analyzed. Very similar results were obtained from all of the methods. Therefore, the sample collection strip and in-house assay can be useful tools for detecting SARS-CoV-2.
- 13 July 2026
- Published by Doc Design and Informatics Co. Ltd. in Turkish Journal of Immunology
Evaluation of Methods and Results Used in Screening and Identification of Anti-HLA Antibodies: A Multicenter Study in Türkiye
Objective: Panel-reactive antibodies (PRA) or anti-human leucocyte antigens (anti-HLAs) are produced by the patient's immune system in response to donors during transplant procedures. Antibodies to HLA are known to develop following blood transfusion, pregnancy, and a history of transplantation. Donor-specific antibodies (DSA) arising in patient serum in response to donor-specific HLA can be detected using the single antigen bead (SAB) test. The objective of this multicentre retrospective study is to analyse the distribution of anti-HLA antibodies in Turkey, mean fluorescence intensity (MFI) values, and to assess the concordance of PRA tests across centres on a national scale. Materials and Methods: The study will include adult patients and their donors who were on the living and cadaveric waiting lists and who underwent PRA screening/identification/SAB tests between 2013-2024. Data on patients' anti-HLA antibodies and demographics will be obtained from 12 tissue typing laboratories. Tests and MFI values will be recorded. The data will undergo rigorous testing for statistical significance using SPSS version 23.0, with a p-value <0.05. Results: This study will reveal the distribution of anti-HLA antibodies across Turkey for the first time, and the effects of sensitization factors will be analysed. The correlation between Class I and II antibody positivity, MFI levels, and demographic data will be evaluated. Discussion: The findings of this study will contribute to advancing laboratory consistency and establishing national test standardisation. It is hypothesized that the obtained data may also provide insights into updating the organ allocation system to include antibody testing. The comparison of PRA tests, SAB methods, and the MFI values will provide a new perspective on laboratory and clinical evaluation. This study aims to enhance the efficacy of patient-donor matching through the identification of shared criteria for pre-transplant immunological risk assessment within the national context. Keywords: MFI, PRA screening/identification, SAB, transplantation
- 13 July 2026
- Published by Doc Design and Informatics Co. Ltd. in Turkish Journal of Immunology
Evaluation of Methods and Results Used in Screening and Identification of Anti-HLA Antibodies: A Multicenter Study in Türkiye
Objective: Panel-reactive antibodies (PRA) or anti-human leucocyte antigens (anti-HLAs) are produced by the patient's immune system in response to donors during transplant procedures. Antibodies to HLA are known to develop following blood transfusion, pregnancy, and a history of transplantation. Donor-specific antibodies (DSA) arising in patient serum in response to donor-specific HLA can be detected using the single antigen bead (SAB) test. The objective of this multicentre retrospective study is to analyse the distribution of anti-HLA antibodies in Turkey, mean fluorescence intensity (MFI) values, and to assess the concordance of PRA tests across centres on a national scale. Materials and Methods: The study will include adult patients and their donors who were on the living and cadaveric waiting lists and who underwent PRA screening/identification/SAB tests between 2013-2024. Data on patients' anti-HLA antibodies and demographics will be obtained from 12 tissue typing laboratories. Tests and MFI values will be recorded. The data will undergo rigorous testing for statistical significance using SPSS version 23.0, with a p-value <0.05. Results: This study will reveal the distribution of anti-HLA antibodies across Turkey for the first time, and the effects of sensitization factors will be analysed. The correlation between Class I and II antibody positivity, MFI levels, and demographic data will be evaluated. Discussion: The findings of this study will contribute to advancing laboratory consistency and establishing national test standardisation. It is hypothesized that the obtained data may also provide insights into updating the organ allocation system to include antibody testing. The comparison of PRA tests, SAB methods, and the MFI values will provide a new perspective on laboratory and clinical evaluation. This study aims to enhance the efficacy of patient-donor matching through the identification of shared criteria for pre-transplant immunological risk assessment within the national context. Keywords: MFI, PRA screening/identification, SAB, transplantation
- Open Access
- 30 June 2026
- Published by Turkish Society of Microbiology
- Vol. 56 (2) , 116-123
Menenjit ve Ensefalit Etkenlerinin Real Time PCR Yöntemiyle Araştırılması
Amaç: Santral sinir sistemi (SSS) enfeksiyonları yüksek morbidite ve mortaliteye sahip olup erken tanı gerektirir. Bu çalışmada, menenjit/ensefalit ön tanısı ile izlenen hastaların beyin omurilik sıvısı (BOS) örneklerinde BioFire FilmArray Menenjit/Ensefalit (ME) Paneli ile saptanan etkenlerin retrospektif olarak değerlendirilmesi amaçlanmıştır.Yöntem: 1 Ocak 2021–31 Aralık 2022 tarihleri arasında üniversite hastanemiz moleküler mikrobiyoloji laboratuvarına gönderilen BOS örneklerine ait ME paneli sonuçları retrospektif olarak incelenmiştir. ME paneli, klinisyen talebi doğrultusunda menenjit/ensefalit ön tanısı bulunan seçilmiş olgularda uygulanmıştır. ME paneli ile etken saptanan örneklerde ayrıca kültür sonuçları değerlendirilmiştir.Bulgular: Toplam 543 BOS örneği çalışmaya dahil edilmiştir. Örneklerin 62’sinde (%10,5) en az bir etken saptanmış; dört olguda eş zamanlı iki etken tespit edilmesiyle toplam 66 mikrobiyal etken belirlenmiştir. Etken saptanan örneklerin 44’ünde (%70,96) en az bir viral etken saptanmış olup, on dokuz örnekte (%30,6) bakteriyel etken, iki örnekte (%3,22) ise Cryptococcus neoformans/gattii nükleik asiti saptanmıştır. Toplam 66 mikrobiyal etken üzerinden yapılan değerlendirmede, en sık saptanan etkenler HHV-6 (%24,2), Streptococcus pneumoniae (%21,2) ve HSV-1 (%18,2) olmuştur. Bakteriyel etken ve C. neoformans/gattii saptanan 21 olgunun 17’sinde kültür sonucu mevcut olup, ME paneli ile kültür uyumu %88,2 olarak bulunmuştur.Sonuç: ME paneli, SSS enfeksiyonlarında etkenin hızlı saptanmasına olanak sağlayan değerli bir tanı aracıdır. Ancak test sonuçları, sınırlı panel içeriği ve olası yalancı pozitif/negatiflikler göz önünde bulundurularak klinik bulgular ve diğer laboratuvar yöntemleri ile birlikte değerlendirilmelidir.
- 30 June 2026
- Published by Turkish Society of Microbiology
- Vol. 56 (2) , 116-123
Open AccessMenenjit ve Ensefalit Etkenlerinin Real Time PCR Yöntemiyle Araştırılması
Amaç: Santral sinir sistemi (SSS) enfeksiyonları yüksek morbidite ve mortaliteye sahip olup erken tanı gerektirir. Bu çalışmada, menenjit/ensefalit ön tanısı ile izlenen hastaların beyin omurilik sıvısı (BOS) örneklerinde BioFire FilmArray Menenjit/Ensefalit (ME) Paneli ile saptanan etkenlerin retrospektif olarak değerlendirilmesi amaçlanmıştır.Yöntem: 1 Ocak 2021–31 Aralık 2022 tarihleri arasında üniversite hastanemiz moleküler mikrobiyoloji laboratuvarına gönderilen BOS örneklerine ait ME paneli sonuçları retrospektif olarak incelenmiştir. ME paneli, klinisyen talebi doğrultusunda menenjit/ensefalit ön tanısı bulunan seçilmiş olgularda uygulanmıştır. ME paneli ile etken saptanan örneklerde ayrıca kültür sonuçları değerlendirilmiştir.Bulgular: Toplam 543 BOS örneği çalışmaya dahil edilmiştir. Örneklerin 62’sinde (%10,5) en az bir etken saptanmış; dört olguda eş zamanlı iki etken tespit edilmesiyle toplam 66 mikrobiyal etken belirlenmiştir. Etken saptanan örneklerin 44’ünde (%70,96) en az bir viral etken saptanmış olup, on dokuz örnekte (%30,6) bakteriyel etken, iki örnekte (%3,22) ise Cryptococcus neoformans/gattii nükleik asiti saptanmıştır. Toplam 66 mikrobiyal etken üzerinden yapılan değerlendirmede, en sık saptanan etkenler HHV-6 (%24,2), Streptococcus pneumoniae (%21,2) ve HSV-1 (%18,2) olmuştur. Bakteriyel etken ve C. neoformans/gattii saptanan 21 olgunun 17’sinde kültür sonucu mevcut olup, ME paneli ile kültür uyumu %88,2 olarak bulunmuştur.Sonuç: ME paneli, SSS enfeksiyonlarında etkenin hızlı saptanmasına olanak sağlayan değerli bir tanı aracıdır. Ancak test sonuçları, sınırlı panel içeriği ve olası yalancı pozitif/negatiflikler göz önünde bulundurularak klinik bulgular ve diğer laboratuvar yöntemleri ile birlikte değerlendirilmelidir.
- 26 March 2026
- Published by Bulent Evcevit University in Medical Journal of Western Black Sea
- Vol. 10 (1) , 60-64
Evaluation of viral respiratory pathogens detected in a tertiary university hospital between 2021 and 2025
Aim: Infections caused by respiratory tract pathogens cause high morbidity and mortality and pose a significant threat to public health. In this study, we aimed to determine the prevalence and seasonal distribution of common respiratory viruses in patients admitted to our university hospital between 2021 and 2025.Material and Methods: Between January 1, 2021 and January 1, 2025, 3131 nasal swab samples from patients with a preliminary diagnosis of acute respiratory tract infection were sent to the Molecular Laboratory of Ondokuz Mayıs University Faculty of Medicine Hospital. 24 different pathogens were detected by multiplex real time polymerase chain reaction method (Qiagen, Germany).Results: Among the 3,131 samples analyzed, one or more viral agents were detected in 1,792 cases (57.23%). The most commonly identified viral pathogens were rhinovirus/enterovirus, respiratory syncytial virus A/B, SARS-CoV-2, and influenza A. The most frequently observed dual infection was influenza A combined with influenza A (subtype H1N1/2009), found in 22% of the co-infected cases. Seasonal distribution analysis showed that rhinovirus/enterovirus infections were more common in autumn, influenza A in winter, and respiratory syncytial virus A/B and SARS-CoV-2 in both autumn and winter months.Conclusion: Determination of the viral pathogen by molecular methods in respiratory tract infections will be useful in preventing unnecessary use of antibiotics with correct treatment. It will also contribute to rapid and accurate management decisions with infection control measures and shorten hospitalization periods.
- 26 March 2026
- Published by Bulent Evcevit University in Medical Journal of Western Black Sea
- Vol. 10 (1) , 60-64
Evaluation of viral respiratory pathogens detected in a tertiary university hospital between 2021 and 2025
Aim: Infections caused by respiratory tract pathogens cause high morbidity and mortality and pose a significant threat to public health. In this study, we aimed to determine the prevalence and seasonal distribution of common respiratory viruses in patients admitted to our university hospital between 2021 and 2025.Material and Methods: Between January 1, 2021 and January 1, 2025, 3131 nasal swab samples from patients with a preliminary diagnosis of acute respiratory tract infection were sent to the Molecular Laboratory of Ondokuz Mayıs University Faculty of Medicine Hospital. 24 different pathogens were detected by multiplex real time polymerase chain reaction method (Qiagen, Germany).Results: Among the 3,131 samples analyzed, one or more viral agents were detected in 1,792 cases (57.23%). The most commonly identified viral pathogens were rhinovirus/enterovirus, respiratory syncytial virus A/B, SARS-CoV-2, and influenza A. The most frequently observed dual infection was influenza A combined with influenza A (subtype H1N1/2009), found in 22% of the co-infected cases. Seasonal distribution analysis showed that rhinovirus/enterovirus infections were more common in autumn, influenza A in winter, and respiratory syncytial virus A/B and SARS-CoV-2 in both autumn and winter months.Conclusion: Determination of the viral pathogen by molecular methods in respiratory tract infections will be useful in preventing unnecessary use of antibiotics with correct treatment. It will also contribute to rapid and accurate management decisions with infection control measures and shorten hospitalization periods.
- 25 March 2026
- Published by MediHealth Academy in Ankyra Medical Journal
- Vol. 5 (2) , 46-49
Evaluation of RPR, TPHA and ELISA test results used in the diagnosis of syphilis at a university hospital
Aims: This study aimed to evaluate the laboratory results of treponemal and non-treponemal serological tests used in the diagnosis of syphilis and to investigate the diagnostic contributions of different testing algorithms. Methods: Between April 2023 and June 2025, serum samples from 600 patients who underwent all three tests in the Microbiology Laboratory were retrospectively analyzed. The Rapid Plasma Reagin (RPR), Treponema pallidum Hemagglutination Assay (TPHA) and Enzyme-Linked Immunosorbent Assay (ELISA) tests were performed according to the manufacturers’ instructions, and the results were evaluated within both conventional and reverse algorithm frameworks. Results: In 89.5% of cases (n=537), all three tests were negative, while at least one test was positive in 10.5% (n=63). ELISA showed the highest positivity rate, with 63 reactive samples. A total of 20 cases were positive across all three tests simultaneously. Samples positive only by ELISA were notably increased in the age group over 60 years. RPR positivity was lower compared to treponemal tests. Within the reverse algorithm, discrepancies between ELISA-positive and RPR-negative results were observed at a notable frequency. Conclusion: Using treponemal tests as the first step in syphilis screening provides a more sensitive approach. Positive results should be confirmed with a second treponemal test, while non-treponemal tests are essential for assessing active infection and treatment monitoring. Higher ELISA positivity in older individuals suggests more false positives. The study underscores the need for laboratory–clinical collaboration and larger prospective studies.
- 25 March 2026
- Published by MediHealth Academy in Ankyra Medical Journal
- Vol. 5 (2) , 46-49
Evaluation of RPR, TPHA and ELISA test results used in the diagnosis of syphilis at a university hospital
Aims: This study aimed to evaluate the laboratory results of treponemal and non-treponemal serological tests used in the diagnosis of syphilis and to investigate the diagnostic contributions of different testing algorithms. Methods: Between April 2023 and June 2025, serum samples from 600 patients who underwent all three tests in the Microbiology Laboratory were retrospectively analyzed. The Rapid Plasma Reagin (RPR), Treponema pallidum Hemagglutination Assay (TPHA) and Enzyme-Linked Immunosorbent Assay (ELISA) tests were performed according to the manufacturers’ instructions, and the results were evaluated within both conventional and reverse algorithm frameworks. Results: In 89.5% of cases (n=537), all three tests were negative, while at least one test was positive in 10.5% (n=63). ELISA showed the highest positivity rate, with 63 reactive samples. A total of 20 cases were positive across all three tests simultaneously. Samples positive only by ELISA were notably increased in the age group over 60 years. RPR positivity was lower compared to treponemal tests. Within the reverse algorithm, discrepancies between ELISA-positive and RPR-negative results were observed at a notable frequency. Conclusion: Using treponemal tests as the first step in syphilis screening provides a more sensitive approach. Positive results should be confirmed with a second treponemal test, while non-treponemal tests are essential for assessing active infection and treatment monitoring. Higher ELISA positivity in older individuals suggests more false positives. The study underscores the need for laboratory–clinical collaboration and larger prospective studies.
- 20 December 2025
- Published by Journal of Biotechnology and Strategic Health Research in JOURNAL OF BIOTECHNOLOGY AND STRATEGIC HEALTH RESEARCH
- Vol. 9 (3) , 184-189
Akut Gastroenteritli Hastalarda Adenovirüs ve Rotavirüs Sıklığına COVID-19 Pandemisinin Etkisinin Araştırılması
Giriş Akut gastroenterit (AGE), karın ağrısı, bulantı, kusma ve ishal gibi belirtilerle seyreden, kısa süreli ancak ciddi sağlık sonuçlarına yol açabilen enfeksiyon hastalıklarından biridir (1,2). Özellikle beş yaş altı çocuklarda önemli bir morbidite ve mortalite sebebi olup, dünya genelinde her yıl milyonlarca vakaya neden olmaktadır (3). Viral etkenler, tüm AGE vakalarının büyük kısmını oluşturmakta; rotavirüs ve adenovirüs ise en sık görülen patojenler arasında yer almaktadır (4,5). Rotavirüs enfeksiyonları, ılıman iklimlerde genellikle kış aylarında ve 2 yaş altı çocuklarda sık görülürken, adenovirüs enfeksiyonları yılın her döneminde izlenebilir ve özellikle tip 40 ile 41 çocukluk çağı gastroenteritlerinde öne çıkmaktadır (6,7). Her iki virüs de fekal-oral yolla bulaşır, çevresel koşullara dirençlidir ve ortak kullanım alanlarında kolayca yayılabilir (5,8). Bu özellikleri nedeniyle hastaneler, kreşler ve bakım evleri gibi kapalı alanlarda salgınlara yol açabilmektedir (9). Klinik olarak rotavirüs ve adenovirüs enfeksiyonları sıklıkla benzer bulgular gösterdiğinden, laboratuvar tanısı hem epidemiyolojik verilerin elde edilmesi hem de uygun tedavi ve enfeksiyon kontrol önlemlerinin uygulanması açısından kritik öneme sahiptir (10,11). 2020 yılında ortaya çıkan COVID-19 pandemisi, yalnızca solunum yolu hastalıklarının seyrini değil, aynı zamanda diğer bulaşıcı hastalıkların epidemiyolojisini de etkilemiştir (11,12). Pandemi sürecinde uygulanan maske kullanımı, el hijyeni, sosyal izolasyon ve ortak yaşam alanlarının kapatılması gibi önlemler; solunum yolu patojenlerinde olduğu gibi, gastrointestinal etkenlerin bulaş dinamiklerini de değiştirebilecek potansiyele sahiptir (11).Bazı viral etkenlerin görülme sıklığında belirgin düşüşler yaşanırken, bazıları neredeyse hiçbir değişiklik tespit edilmemiştir (12). Bu nedenle, COVID-19 pandemisinin AGE etkenleri üzerindeki olası etkilerinin incelenmesi hem halk sağlığı politikalarının şekillendirilmesi hem de olası yeni salgınlara karşı hazırlıklı olunması açısından önemlidir. Bu çalışma, akut gastroenterit tanısı ile başvuran hastalarda rotavirüs ve adenovirüs sıklığının yaş, cinsiyet ve mevsimsel dağılımlarını inceleyerek, COVID-19 pandemisinin bu patojenlerin görülme oranları üzerindeki olası etkilerini değerlendirmeyi amaçlamaktadır.
- 20 December 2025
- Published by Journal of Biotechnology and Strategic Health Research in JOURNAL OF BIOTECHNOLOGY AND STRATEGIC HEALTH RESEARCH
- Vol. 9 (3) , 184-189
Akut Gastroenteritli Hastalarda Adenovirüs ve Rotavirüs Sıklığına COVID-19 Pandemisinin Etkisinin Araştırılması
Giriş Akut gastroenterit (AGE), karın ağrısı, bulantı, kusma ve ishal gibi belirtilerle seyreden, kısa süreli ancak ciddi sağlık sonuçlarına yol açabilen enfeksiyon hastalıklarından biridir (1,2). Özellikle beş yaş altı çocuklarda önemli bir morbidite ve mortalite sebebi olup, dünya genelinde her yıl milyonlarca vakaya neden olmaktadır (3). Viral etkenler, tüm AGE vakalarının büyük kısmını oluşturmakta; rotavirüs ve adenovirüs ise en sık görülen patojenler arasında yer almaktadır (4,5). Rotavirüs enfeksiyonları, ılıman iklimlerde genellikle kış aylarında ve 2 yaş altı çocuklarda sık görülürken, adenovirüs enfeksiyonları yılın her döneminde izlenebilir ve özellikle tip 40 ile 41 çocukluk çağı gastroenteritlerinde öne çıkmaktadır (6,7). Her iki virüs de fekal-oral yolla bulaşır, çevresel koşullara dirençlidir ve ortak kullanım alanlarında kolayca yayılabilir (5,8). Bu özellikleri nedeniyle hastaneler, kreşler ve bakım evleri gibi kapalı alanlarda salgınlara yol açabilmektedir (9). Klinik olarak rotavirüs ve adenovirüs enfeksiyonları sıklıkla benzer bulgular gösterdiğinden, laboratuvar tanısı hem epidemiyolojik verilerin elde edilmesi hem de uygun tedavi ve enfeksiyon kontrol önlemlerinin uygulanması açısından kritik öneme sahiptir (10,11). 2020 yılında ortaya çıkan COVID-19 pandemisi, yalnızca solunum yolu hastalıklarının seyrini değil, aynı zamanda diğer bulaşıcı hastalıkların epidemiyolojisini de etkilemiştir (11,12). Pandemi sürecinde uygulanan maske kullanımı, el hijyeni, sosyal izolasyon ve ortak yaşam alanlarının kapatılması gibi önlemler; solunum yolu patojenlerinde olduğu gibi, gastrointestinal etkenlerin bulaş dinamiklerini de değiştirebilecek potansiyele sahiptir (11).Bazı viral etkenlerin görülme sıklığında belirgin düşüşler yaşanırken, bazıları neredeyse hiçbir değişiklik tespit edilmemiştir (12). Bu nedenle, COVID-19 pandemisinin AGE etkenleri üzerindeki olası etkilerinin incelenmesi hem halk sağlığı politikalarının şekillendirilmesi hem de olası yeni salgınlara karşı hazırlıklı olunması açısından önemlidir. Bu çalışma, akut gastroenterit tanısı ile başvuran hastalarda rotavirüs ve adenovirüs sıklığının yaş, cinsiyet ve mevsimsel dağılımlarını inceleyerek, COVID-19 pandemisinin bu patojenlerin görülme oranları üzerindeki olası etkilerini değerlendirmeyi amaçlamaktadır.